The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard’s PowerPort devices are defective, leading to blood infections, thrombosis or fractures.
The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard’s PowerPort devices are defective, leading to blood infections, thrombosis or fractures.

